These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16836563)

  • 1. Different behavior of erythrovirus B19 and torquetenovirus in response to a single step of albumin purification.
    Azzi A; Maggi F; Zakrzewska K; Menconi MC; Di Pietro N; Salotti V; Farina C; Andreoli E; Fiorentino B; Angelini C; Corcioli F; Bendinelli M
    Transfusion; 2006 Jul; 46(7):1162-7. PubMed ID: 16836563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of nanofiltration in removing small non-enveloped viruses from three different plasma-derived products.
    Menconi MC; Maggi F; Zakrzewska K; Salotti V; Giovacchini P; Farina C; Andreoli E; Corcioli F; Bendinelli M; Azzi A
    Transfus Med; 2009 Aug; 19(4):213-7. PubMed ID: 19706139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of small nonenveloped viruses by antibody-enhanced nanofiltration during the manufacture of plasma derivatives.
    Kreil TR; Wieser A; Berting A; Spruth M; Medek C; Pölsler G; Gaida T; Hämmerle T; Teschner W; Schwarz HP; Barrett PN
    Transfusion; 2006 Jul; 46(7):1143-51. PubMed ID: 16836561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different susceptibility of B19 virus and mice minute virus to low pH treatment.
    Boschetti N; Niederhauser I; Kempf C; Stühler A; Löwer J; Blümel J
    Transfusion; 2004 Jul; 44(7):1079-86. PubMed ID: 15225251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genoprevalence in human tissues of TT-virus genotype 6.
    Kakkola L; Kaipio N; Hokynar K; Puolakkainen P; Mattila PS; Kokkola A; Partio EK; Eis-Hübinger AM; Söderlund-Venermo M; Hedman K
    Arch Virol; 2004 Jun; 149(6):1095-106. PubMed ID: 15168197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral infectivity of albumin and plasma protein fraction.
    Erstad BL
    Pharmacotherapy; 1996; 16(6):996-1001. PubMed ID: 8947970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and analysis of a novel parvovirus B19 Genotype 3 isolate in the United States.
    Rinckel LA; Buno BR; Gierman TM; Lee DC
    Transfusion; 2009 Jul; 49(7):1488-92. PubMed ID: 19389024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proficiency testing study to evaluate laboratory performance for the detection of different genotypes of parvovirus B19.
    Baylis SA; Buchheit KH
    Vox Sang; 2009 Jul; 97(1):13-20. PubMed ID: 19416495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses.
    Mani B; Gerber M; Lieby P; Boschetti N; Kempf C; Ros C
    Transfusion; 2007 Oct; 47(10):1765-74. PubMed ID: 17880601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays.
    Koppelman MH; Rood IG; Fryer JF; Baylis SA; Cuypers HT
    Vox Sang; 2007 Oct; 93(3):208-15. PubMed ID: 17845257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of human Torque teno virus in streams crossing the city of Manaus, Brazilian Amazon.
    Diniz-Mendes L; Paula VS; Luz SL; Niel C
    J Appl Microbiol; 2008 Jul; 105(1):51-8. PubMed ID: 18217932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the virus-elimination efficacy of nanofiltration (Viresolve NFP) for the parvovirus B19 and hepatitis A virus].
    Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS; Kim IS
    Korean J Lab Med; 2010 Feb; 30(1):45-50. PubMed ID: 20197722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of small non-enveloped viruses by nanofiltration.
    Yokoyama T; Murai K; Murozuka T; Wakisaka A; Tanifuji M; Fujii N; Tomono T
    Vox Sang; 2004 May; 86(4):225-9. PubMed ID: 15144526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of parvovirus B19 during STIM-4 vapor heat treatment of three coagulation factor concentrates.
    Berting A; Modrof J; Unger U; Gessner M; Klotz A; Poelsler G; Kreil TR
    Transfusion; 2008 Jun; 48(6):1220-6. PubMed ID: 18410254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression towards AIDS leads to increased Torque teno virus and Torque teno minivirus titers in tissues of HIV infected individuals.
    Thom K; Petrik J
    J Med Virol; 2007 Jan; 79(1):1-7. PubMed ID: 17133553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation and neutralization of parvovirus B19 Genotype 3.
    Blümel J; Rinckel LA; Lee DC; Roth NJ; Baylis SA
    Transfusion; 2012 Jul; 52(7):1490-7. PubMed ID: 22339291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex real-time PCR for the detection and quantification of latent and persistent viral genomes in cellular or plasma blood fractions.
    Compston LI; Sarkobie F; Li C; Candotti D; Opare-Sem O; Allain JP
    J Virol Methods; 2008 Jul; 151(1):47-54. PubMed ID: 18479760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral safety of Nanogam, a new 15 nm-filtered liquid immunoglobulin product.
    Terpstra FG; Parkkinen J; Tölö H; Koenderman AH; Ter Hart HG; von Bonsdorff L; Törmä E; van Engelenburg FA
    Vox Sang; 2006 Jan; 90(1):21-32. PubMed ID: 16359352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular detection of bovine and porcine Torque teno virus in plasma and feces.
    Brassard J; Gagné MJ; Lamoureux L; Inglis GD; Leblanc D; Houde A
    Vet Microbiol; 2008 Jan; 126(1-3):271-6. PubMed ID: 17723280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
    Parsyan A; Addo-Yobo E; Owusu-Ofori S; Akpene H; Sarkodie F; Allain JP
    Transfusion; 2006 Sep; 46(9):1593-600. PubMed ID: 16965589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.